KaiPharm Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

KaiPharm General Information

Description

Developer of a biotech platform designed for drug discovery and development. The company's platform analyzes drug-induced transcriptome data and allows monoclonal antibody analysis, and identification of novel indications for a given drug, enabling pharmaceutical industries to stay ahead through a combination of information technology and laboratory science.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Ewha Womans University Science Hall A-206
  • 52, Ewhayeodae-gil, Seodaemun-gu
  • Seoul, 03760
  • South Korea
Primary Industry
Discovery Tools (Healthcare)
Corporate Office
  • Ewha Womans University Science Hall A-206
  • 52, Ewhayeodae-gil, Seodaemun-gu
  • Seoul, 03760
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

KaiPharm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 06-Oct-2024 Completed Out of Business
4. Early Stage VC (Series A) 10-Feb-2020 Completed Generating Revenue
3. Seed Round 01-Aug-2019 Completed Generating Revenue
2. Angel (individual) 01-Mar-2019 $200K $200K Completed Generating Revenue
1. Accelerator/Incubator 01-Nov-2018 Completed Generating Revenue
To view KaiPharm’s complete valuation and funding history, request access »

KaiPharm Patents

KaiPharm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024085557-A1 Composition for preventing or treating oscar-induced diseases, comprising adefovir as active ingredient Inactive 19-Oct-2022
WO-2024085558-A1 Composition for preventing or treating oscar-induced diseases, containing brivudin as active ingredient Inactive 19-Oct-2022
WO-2023191166-A1 Prediction method and analysis device for drug adverse reactions to target drug Inactive 29-Mar-2022
US-20220238189-A1 Method of extracting drug information based on bioactivity data, method of constructing drug screening library, and analysis apparatus Inactive 25-Jan-2021 G16C20/62

KaiPharm FAQs

  • When was KaiPharm founded?

    KaiPharm was founded in 2018.

  • Where is KaiPharm headquartered?

    KaiPharm is headquartered in Seoul, South Korea.

  • What industry is KaiPharm in?

    KaiPharm’s primary industry is Discovery Tools (Healthcare).

  • Is KaiPharm a private or public company?

    KaiPharm is a Private company.

  • What is KaiPharm’s current revenue?

    The current revenue for KaiPharm is .

  • How much funding has KaiPharm raised over time?

    KaiPharm has raised $6.15M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process